Nosocomial Infections: Market Impact on Diagnostics and Therapeutics
A nosocomial, or hospital-acquired, infection is a new infection that is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, This type of infection is also known as a hospital-acquired infection (or more generically healthcare-associated infections).
Marketing planners in the pharmaceutical or diagnostic industries should have an understanding of the market impact of nosocomial infections, as it will be an important consideration in these markets into the near future.
This report. Hospital Acquired Infections (Nosocomial) : Diagnostic and Pharmaceutical Market Considerations discusses the following in detail:
- Acinetobacter baumannii
- Clostridium difficile
- Gastroenteritis
- Hospital-acquired pneumonia (HAP) and ventilator associated pneumonia (VAP)
- Methicillin resistant staphylococcus aureus (MRSA)
- Pseudomonas aeruginosa
- Staphylococcus aureus
- Stenotrophomonas maltophilia
- Tuberculosis
- Urinary tract infection
- Vancomycin-resistant enterococcus
This report covers nosocomial infection diagnosis and therapeutics in a broad sense. It does not go into the detail of the dynamics of individual products in the marketplace. It discusses, however, the status of the field of nosocomial infection diagnostics and therapeutics, as a setting-specific field of application.
The Most Recent and Relevant Epidemiological Statistics on HAIs
There is no 'noscomial infection' market per se, it is reflected in sales and revenues of all infectious disease testing and therapeutics. Therefore the authors of this report consider primarily the epidemiological considerations and the sizes patient groups both in the United States and globally, where available. They have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis. Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the major markets for nosocomial diagnostic and therapeutic products).
In many instances, the authors have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital environment in order to try and construct a picture of the nosocomial testing needs.
Estimates of Market Impact
As mentioned above, the primary focus of this report is on the bacterial form of nosocomial infections, and those with significant impact on the hospital setting and markets. In looking at these infections, we consider the diagnostic and therapeutics technologies that are currently available and attempt to project trends in these product areas. Company Profiles and Competitive Assessment
This report examines the key players in HAI infection diagnostics and pharmaceutical treatement, their revenues, and activity in the market. To some extent, we are limited by the activity of the industries associated with the diagnosis and treatment of these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology. This presages opportunities for new competitors
Other users found this report page using the following search terms: Acinetobacter baumannii Clostridium difficile Gastroenteritis Hospital-acquired pneumonia HAP ventilator associated pneumonia VAP Methicillin resistant staphylococcus aureus MRSA Pseudomonas aeruginosa Staphylococcus aureus Stenotrophomonas maltophilia Tuberculosis Urinary tract infection Vancomycin-resistant enterococcus nosocomial infection infections market diagnostic impact diagnostics report pseudomonas therapeutics
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.
Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.